ResearcherKorea Advanced Institute of Science and TechnologyActive in the last 2 years
Jungwhoi Lee
Matched on ORCID iD 0000-0002-3453-0478; OpenAlex author ID A5103176642. Sources: OpenAlex.
Their work
- Papers
- 15
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 5
2015: 2 papers · 2016: 3 papers · 2017: 1 paper · 2018: none · 2019: 5 papers · 2020: 3 papers · 2021: none · 2022: none · 2023: none · 2024: 1 paper
Papers 15
- Corrigendum to "Scattered DUSP28 is a novel biomarker responsible for aggravating malignancy via the autocrine and paracrine signaling in metastatic pancreatic… Co-author DOI 10.1016/j.canlet.2023.216454↗
- Association of Jagged1 expression with malignancy and prognosis in human pancreatic cancer. Co-author DOI 10.1007/s13402-020-00527-3↗
- Silencing Delta-like 1 Expression Induces Migratory Features in Pancreatic Cancer Cells Through Stimulation of Src and p38 Signalling Pathway. Co-author DOI 10.21873/anticanres.14075↗
- Differential Dependency of Human Pancreatic Cancer Cells on Targeting PTEN via PLK 1 Expression. Co-author DOI 10.3390/cancers12020277↗
- Scattered DUSP28 is a novel biomarker responsible for aggravating malignancy via the autocrine and paracrine signaling in metastatic pancreatic cancer. Co-author DOI 10.1016/j.canlet.2019.03.006↗
- Combined administration of naringenin and hesperetin with optimal ratio maximizes the anti-cancer effect in human pancreatic cancer via down regulation of FAK … Co-author DOI 10.1016/j.phymed.2018.11.022↗
- Blockade of integrin α3 attenuates human pancreatic cancer via inhibition of EGFR signalling. Co-author DOI 10.1038/s41598-019-39628-x↗
- Identification of Matrix Metalloproteinase 11 as a Prognostic Biomarker in Pancreatic Cancer. Co-author DOI 10.21873/anticanres.13801↗
- 2-Methoxy-4-vinylphenol Attenuates Migration of Human Pancreatic Cancer Cells via Blockade of FAK and AKT Signaling. Co-author DOI 10.21873/anticanres.13883↗
- Autocrine DUSP28 signaling mediates pancreatic cancer malignancy via regulation of PDGF-A. Co-author DOI 10.1038/s41598-017-13023-w↗
- DUSP28 links regulation of Mucin 5B and Mucin 16 to migration and survival of AsPC-1 human pancreatic cancer cells. Co-author DOI 10.1007/s13277-016-5079-x↗
- Kaempferol Inhibits Pancreatic Cancer Cell Growth and Migration through the Blockade of EGFR-Related Pathway In Vitro. Co-author DOI 10.1371/journal.pone.0155264↗
- Quercetin-3-O-glucoside suppresses pancreatic cancer cell migration induced by tumor-deteriorated growth factors in vitro. Co-author DOI 10.3892/or.2016.4598↗
- Quercetin 3-O-glucoside suppresses epidermal growth factor-induced migration by inhibiting EGFR signaling in pancreatic cancer cells. Co-author DOI 10.1007/s13277-015-3682-x↗
- Blockade of dual-specificity phosphatase 28 decreases chemo-resistance and migration in human pancreatic cancer cells. Co-author DOI 10.1038/srep12296↗
Closest collaborators
The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jae Hoon Kim · 9 shared papers, 2015–2020 · strength 1.04
- Paper Silencing Delta-like 1 Expression Induces Migratory Features in Pancreatic Cancer Cells Through Stimulation of Src and … DOI 10.21873/anticanres.14075↗
- Paper Combined administration of naringenin and hesperetin with optimal ratio maximizes the anti-cancer effect in human pancr… DOI 10.1016/j.phymed.2018.11.022↗
- Paper Identification of Matrix Metalloproteinase 11 as a Prognostic Biomarker in Pancreatic Cancer. DOI 10.21873/anticanres.13801↗
- Jae-Hoon Kim · 3 shared papers, 2019–2024 · strength 0.62
- Paper Corrigendum to "Scattered DUSP28 is a novel biomarker responsible for aggravating malignancy via the autocrine and para… DOI 10.1016/j.canlet.2023.216454↗
- Paper Differential Dependency of Human Pancreatic Cancer Cells on Targeting PTEN via PLK 1 Expression. DOI 10.3390/cancers12020277↗
- Paper 2-Methoxy-4-vinylphenol Attenuates Migration of Human Pancreatic Cancer Cells via Blockade of FAK and AKT Signaling. DOI 10.21873/anticanres.13883↗
- Jae‐Hoon Kim · 2 shared papers, 2016–2020 · strength 0.26
- Jae Hoon Kim · 1 shared paper, 2019 · strength 0.14
- Da-Hye Kim · 1 shared paper, 2019 · strength 0.10
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.